Sponsor content
61 result(s) found, displaying 31 to 40
-
Australian public assessment report (AusPar)Raniviz (ranibizumab) has been approved for the treatment of neovascular age-related macular degeneration, diabetic macular oedema, proliferative diabetic retinopathy, choroidal neovascularisation and macular oedema.
-
Cancellation by sponsorRequested by Actor Pharmaceuticals Pty Ltd
-
Prescription medicine registrationActive ingredients: lisdexamfetamine dimesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Prunelax Syrup.
-
Prescription medicine decision summaryRaniviz (ranibizumab) is approved to treat visual impairment issues.
-
Prescription medicine registrationActive ingredients: Ranibizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Sinupret Syrup.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Kenkay Extra Relief Face Cream.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KenKay Extra Relief Hand Balm.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Sinupret Forte.